Next Edge Capital Corp. ("Next Edge" or the "Manager") announced that a preliminary prospectus for CMP Next Edge 2025 Critical and Precious Metals Short Duration Flow-Through Limited Partnership (the ...

Yet, despite the immense potential of the field, biologics have remained largely untapped. Now, amid a wave of innovation, investors and drugmakers are putting their weight behind the drug class.

Biologics are among the newest drugs available for treating ulcerative colitis. They can be especially helpful for those who haven’t found relief yet. Biologics are a class of genetically ...

AbbVie has broken ground on a new $223 million expansion of its biologics manufacturing facility in Singapore, creating around 100 new jobs. The new investment will grow its workforce at the site ...

Access WuXi Biologics stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily. Investing.com - Financial Markets Worldwide ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Zydus Lifesciences Ltd. expands its global biologics CDMO capabilities by acquiring Agenus Inc.'s U.S.-based facilities. The acquisition enables Zydus to serve the biotech sector with advanced ...

Zydus Lifesciences has acquired a 5.9% stake in U.S.-based Agenus Inc for $16 million, marking its entry into the global biologics CDMO sector. This deal provides Zydus access to Agenus's California ...